
Amanda Marie Haney
Examiner (ID: 12635, Phone: (571)272-8668 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682 |
| Total Applications | 996 |
| Issued Applications | 284 |
| Pending Applications | 141 |
| Abandoned Applications | 611 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20093719
[patent_doc_number] => 20250223655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 19/088496
[patent_app_country] => US
[patent_app_date] => 2025-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19088496
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/088496 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | Mar 23, 2025 | Pending |
Array
(
[id] => 20093719
[patent_doc_number] => 20250223655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 19/088496
[patent_app_country] => US
[patent_app_date] => 2025-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19088496
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/088496 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | Mar 23, 2025 | Pending |
Array
(
[id] => 20093692
[patent_doc_number] => 20250223628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 19/012392
[patent_app_country] => US
[patent_app_date] => 2025-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19012392
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/012392 | METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY | Jan 6, 2025 | Pending |
Array
(
[id] => 20093692
[patent_doc_number] => 20250223628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 19/012392
[patent_app_country] => US
[patent_app_date] => 2025-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19012392
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/012392 | METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY | Jan 6, 2025 | Pending |
Array
(
[id] => 19449303
[patent_doc_number] => 20240309433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHOD FOR EVALUATING TEA PLANT (+)-CATECHIN CONTENT
[patent_app_type] => utility
[patent_app_number] => 18/662886
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662886
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662886 | Method for evaluating tea plant (+)-catechin content | May 12, 2024 | Issued |
Array
(
[id] => 20173261
[patent_doc_number] => 12391995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Epigenetic markers and related methods and means for the detection and management of certain cancers
[patent_app_type] => utility
[patent_app_number] => 18/418913
[patent_app_country] => US
[patent_app_date] => 2024-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 21
[patent_no_of_words] => 44300
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/418913 | Epigenetic markers and related methods and means for the detection and management of certain cancers | Jan 21, 2024 | Issued |
Array
(
[id] => 19631540
[patent_doc_number] => 20240409989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA
[patent_app_type] => utility
[patent_app_number] => 18/404829
[patent_app_country] => US
[patent_app_date] => 2024-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18404829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/404829 | METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA | Jan 3, 2024 | Pending |
Array
(
[id] => 19332883
[patent_doc_number] => 20240247313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => SEROTONIN TRANSPORTER GENE AND TREATMENT OF OPIOID-RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/394729
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394729
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394729 | Serotonin transporter gene and treatment of opioid-related disorders | Dec 21, 2023 | Issued |
Array
(
[id] => 20329985
[patent_doc_number] => 12460252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => MLH1 methylation assay
[patent_app_type] => utility
[patent_app_number] => 18/535773
[patent_app_country] => US
[patent_app_date] => 2023-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 7
[patent_no_of_words] => 9235
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 480
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/535773 | MLH1 methylation assay | Dec 10, 2023 | Issued |
Array
(
[id] => 19345598
[patent_doc_number] => 20240254561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/527076
[patent_app_country] => US
[patent_app_date] => 2023-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527076
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/527076 | METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS | Nov 30, 2023 | Pending |
Array
(
[id] => 19404919
[patent_doc_number] => 20240288430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 18/513107
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513107 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER | Nov 16, 2023 | Abandoned |
Array
(
[id] => 18955598
[patent_doc_number] => 20240043925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => COMPOSITIONS AND METHODS OF MAKING GENE EXPRESSION LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 18/490390
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/490390 | COMPOSITIONS AND METHODS OF MAKING GENE EXPRESSION LIBRARIES | Oct 18, 2023 | Pending |
Array
(
[id] => 19083447
[patent_doc_number] => 20240110248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA
[patent_app_type] => utility
[patent_app_number] => 18/379355
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379355
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379355 | Extract from a body fluid comprising a micro RNA | Oct 11, 2023 | Issued |
Array
(
[id] => 19083447
[patent_doc_number] => 20240110248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA
[patent_app_type] => utility
[patent_app_number] => 18/379355
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379355
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379355 | Extract from a body fluid comprising a micro RNA | Oct 11, 2023 | Issued |
Array
(
[id] => 19083447
[patent_doc_number] => 20240110248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA
[patent_app_type] => utility
[patent_app_number] => 18/379355
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379355
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379355 | Extract from a body fluid comprising a micro RNA | Oct 11, 2023 | Issued |
Array
(
[id] => 20433441
[patent_doc_number] => 12503733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
[patent_app_type] => utility
[patent_app_number] => 18/240789
[patent_app_country] => US
[patent_app_date] => 2023-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47277
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18240789
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/240789 | Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease | Aug 30, 2023 | Issued |
Array
(
[id] => 19067670
[patent_doc_number] => 20240102096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => METHOD OF TREATMENT WITH TRADIPITANT
[patent_app_type] => utility
[patent_app_number] => 18/448868
[patent_app_country] => US
[patent_app_date] => 2023-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18448868
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/448868 | METHOD OF TREATMENT WITH TRADIPITANT | Aug 10, 2023 | Pending |
Array
(
[id] => 19724412
[patent_doc_number] => 20250027163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => COMPOSITIONS AND METHODS FOR CHARACTERIZING ZDHHC1 DNA
[patent_app_type] => utility
[patent_app_number] => 18/353647
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18353647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/353647 | COMPOSITIONS AND METHODS FOR CHARACTERIZING ZDHHC1 DNA | Jul 16, 2023 | Pending |
Array
(
[id] => 19793585
[patent_doc_number] => 12234519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Kit, device, and method for detecting bladder cancer
[patent_app_type] => utility
[patent_app_number] => 18/339400
[patent_app_country] => US
[patent_app_date] => 2023-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 49
[patent_no_of_words] => 81451
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339400
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/339400 | Kit, device, and method for detecting bladder cancer | Jun 21, 2023 | Issued |
Array
(
[id] => 19265722
[patent_doc_number] => 20240209421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => SINGLE-BUFFER COMPOSITIONS FOR NUCLEIC ACID DETECTION
[patent_app_type] => utility
[patent_app_number] => 18/334320
[patent_app_country] => US
[patent_app_date] => 2023-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/334320 | SINGLE-BUFFER COMPOSITIONS FOR NUCLEIC ACID DETECTION | Jun 12, 2023 | Pending |